Vaccine News and Research

Latest Vaccine News and Research

Homelessness increases risk of infection for injecting drug users

A new report from the Health Protection Agency shows that around three-quarters of injecting drug users (IDUs) have been homeless at some point. In addition, those who have been homeless have higher levels of injecting risk and associated infections, primarily through the sharing of needles and low standards of hygiene.

29 Oct 2007

Whole parasite malaria vaccine to be manufactured for clinical trials

Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.

29 Oct 2007

Ten tips to help asthma-proof your home

The onset of winter cold and flu season combined with colder, short days unfortunately all contribute to increased asthma symptoms for many children.

28 Oct 2007

Cancer patients not getting live-saving flu and pneumonia shots

Although flu and pneumonia can be lethal for cancer patients, more than one quarter of patients undergoing radiation therapy are not complying with national guidelines to be vaccinated against these potentially life-threatening yet preventable illnesses, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

28 Oct 2007

Nasal flu vaccine given the green light for toddlers

A federal advisory panel in the U.S. has given the recommendation that a nasal influenza vaccine can be use in healthy children as young as two.

28 Oct 2007

Johns Hopkins details scientific breakthroughs in malaria prevention and treatment

"Breaking the Cycle" chronicles five years of scientific discovery conducted by researchers at the Johns Hopkins Malaria Research Institute (JHMRI).

24 Oct 2007

Canadians would welcome HPV vaccine if it were free

Canadians would welcome a vaccine against the human papillomavirus (HPV) if it were introduced at no charge, a Quebec, Canada survey suggests.

24 Oct 2007

Novel strategy to inactivate Venezuelan equine encephalitis virus

A collaborative team of scientists from the Uniformed Services University of the Health Sciences (USU) and the National Cancer Institute (NCI) have developed a novel strategy to inactivate highly virulent Venezuelan equine encephalitis virus (VEEV) that can infect and kill both animals and humans.

24 Oct 2007

Influenza vaccine production capacity on the rise

Recent scientific advances and increased vaccine manufacturing capacity have prompted experts to increase their projections of how many pandemic influenza vaccine courses can be made available in the coming years.

24 Oct 2007

In the event of a bird flu pandemic more vaccine will be ready

The World Health Organization (WHO) has revised it's estimate of how much bird flu vaccine could be available were a pandemic scenario to unfold.

24 Oct 2007

New flu pandemic plans for U.S.

In the event of a flu pandemic in the United States new government plans detail who will be the first to get vaccinated.

24 Oct 2007

Link between obesity and viral infections

Experts don't dispute the important role that diet and activity play in maintaining a healthy weight.

23 Oct 2007

Stanford seeks volunteers for flu vaccine study

Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital are looking for adults and children to participate in three studies that will help them better understand how the flu vaccine works in people of different ages.

22 Oct 2007

Microbix Biosystems granted U.S. patent for its influenza vaccine

Microbix Biosystems Inc. has been granted a patent by the U.S. Patent Office for its technology - VIRUSMAX - which enables vaccine manufacturers to double the amount of influenza vaccine they produce each year.

22 Oct 2007

Educating poor in India helps health and well-being

Simply informing the poor about government-provided health, educational, and social services they are entitled to could empower them to take greater advantage of free or low-cost public services, a study in India suggests.

22 Oct 2007

The truth about your immune system

Vitamins, minerals, and herbal supplements can help complement a healthy diet and lifestyle, but consumers shouldn't count on them to boost their immune response, says the new edition of a Harvard Medical School report, The Truth About Your Immune System: What you need to know.

22 Oct 2007

Human cytomegalovirus may help doctors treat glioblastoma multiforme

A common human virus may prove useful in attacking the deadliest form of brain tumors, according to a study by researchers at Duke's Preston Robert Tisch Brain Tumor Center.

22 Oct 2007

Sanofi Pasteur receives FDA approval of Menactra meningococcal vaccine for children

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), to include children 2 years through 10 years of age.

22 Oct 2007

Fight against HIV needs local scientists

Scientists from developing countries are vitally important in the fight against HIV and they must be given the proper resources to conduct their work, according to a new commentary published today in the journal Nature Immunology.

22 Oct 2007

GenVec receives extra funding for adenovector-based HIV vaccines program

GenVec, Inc. has announced that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has executed its sixth option period (year seven) under its multi-year collaboration with GenVec to develop and manufacture novel adenovector-based HIV vaccines.

22 Oct 2007